Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide mechanism and metabolic effects in severe obesity
2008-001869-29Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jul 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of exenatide in obesity (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Hepatic glucose retention. Started Jul 2008; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on 2008-001869-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001869-29.